Qiagen NV (QIA) - Product Pipeline Analysis, 2019 Update
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Qiagen NV (Qiagen) is a provider of molecular testing solutions. The companys sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers its products through subsidiaries and a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Qiagen NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Qiagen NV (Qiagen) is a provider of molecular testing solutions. The companys sample technologies help isolate and process DNA, RNA and proteins from samples such as blood and tissue; assay technologies to identify the genetic information of a pathogen in a tumor; bioinformatics solutions to analyze and interpret genomic data; and solutions to automate the use of consumables into efficient molecular testing workflows. It serves human healthcare, forensics, veterinary diagnostics, food safety testing, pharmaceutical and biotechnology and life sciences research markets. The company offers its products through subsidiaries and a network of independent distributors. It has operations in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Qiagen is headquartered in Venlo, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Qiagen NV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
TABLE OF CONTENTS
Qiagen NV Company Overview
Qiagen NV Company Snapshot
Qiagen NV Pipeline Products and Ongoing Clinical Trials Overview
Qiagen NV Pipeline Analysis Overview
Business Description
Qiagen NV - Key Facts
Qiagen NV - Major Products and Services
Qiagen NV Pipeline Products by Development Stage
Qiagen NV Ongoing Clinical Trials by Trial Status
Qiagen NV Pipeline Products Overview
AdnaTest OvarianCancerSelect
AdnaTest OvarianCancerSelect Product Overview
AdnaTest ProstateCancerDetect
AdnaTest ProstateCancerDetect Product Overview
AR-V7 Companion Diagnostic Test
AR-V7 Companion Diagnostic Test Product Overview
Blood Based Test - Colorectal Cancer
Blood Based Test - Colorectal Cancer Product Overview
Colon Cancer Test - Stage III And IV Patient
Colon Cancer Test - Stage III And IV Patient Product Overview
Companion Diagnostic Assay - EGFR vIII
Companion Diagnostic Assay - EGFR vIII Product Overview
Companion Diagnostic Assay - MGCD265
Companion Diagnostic Assay - MGCD265 Product Overview
Companion Diagnostic Assay - Oncology
Companion Diagnostic Assay - Oncology Product Overview
Companion Diagnostic Test - ASP5878
Companion Diagnostic Test - ASP5878 Product Overview
Companion Diagnostic Test - ASP8273
Companion Diagnostic Test - ASP8273 Product Overview
Companion Diagnostic Test - Binimetinib
Companion Diagnostic Test - Binimetinib Product Overview
Companion Diagnostic Test - EZH2 Y641
Companion Diagnostic Test - EZH2 Y641 Product Overview
Companion Diagnostic Test - IDH1/IDH2 Gene
Companion Diagnostic Test - IDH1/IDH2 Gene Product Overview
DiagCORE Blood Culture Identification Panel
DiagCORE Blood Culture Identification Panel Product Overview
DiagCORE Central Nervous System Panel
DiagCORE Central Nervous System Panel Product Overview
DiagCORE Gastrointestinal Panel
DiagCORE Gastrointestinal Panel Product Overview
DiagCORE Pneumonia Panel
DiagCORE Pneumonia Panel Product Overview
Diagnostic Test - FGFR-TACC
Diagnostic Test - FGFR-TACC Product Overview
Diagnostic Test - T-Cell Lymphoma
Diagnostic Test - T-Cell Lymphoma Product Overview
GeneRead QIAact Lung All-in-One Assay
GeneRead QIAact Lung All-in-One Assay Product Overview
GeneReader NGS - Leukemia Panel
GeneReader NGS - Leukemia Panel Product Overview
GeneReader NGS - MPN Panel
GeneReader NGS - MPN Panel Product Overview
GeneReader NGS System
GeneReader NGS System Product Overview
GeneReader NGS System - BRCA Liquid Biopsy Assay
GeneReader NGS System - BRCA Liquid Biopsy Assay Product Overview
GeneReader NGS System - FFPE BRCA Assay
GeneReader NGS System - FFPE BRCA Assay Product Overview
GeneReader NGS System - Infectious Disease
GeneReader NGS System - Infectious Disease Product Overview
Genetic Test - Prostate Cancer
Genetic Test - Prostate Cancer Product Overview
ipsogen JAK2 RGQ PCR Kit
ipsogen JAK2 RGQ PCR Kit Product Overview
miRNA Biomarker - Cancer of Unknown Primary
miRNA Biomarker - Cancer of Unknown Primary Product Overview
miRNA Test - Endometrial Cancer
miRNA Test - Endometrial Cancer Product Overview
miRNA Test - Lung Cancer
miRNA Test - Lung Cancer Product Overview
miRNA test - Ovarian Cancer
miRNA test - Ovarian Cancer Product Overview
Modaplex System - B-Cell Lymphoma Panel
Modaplex System - B-Cell Lymphoma Panel Product Overview
Modaplex System - BCR-ABL Panel
Modaplex System - BCR-ABL Panel Product Overview
Modaplex System - Cancer
Modaplex System - Cancer Product Overview
Modaplex System - cMET Mutation Panel
Modaplex System - cMET Mutation Panel Product Overview
Modaplex System - Copy Number Variation
Modaplex System - Copy Number Variation Product Overview
Modaplex System - Deletions
Modaplex System - Deletions Product Overview
Modaplex System - Drug Metabolism
Modaplex System - Drug Metabolism Product Overview
Modaplex System - EML4-ALK
Modaplex System - EML4-ALK Product Overview
Modaplex System - Expression Panels
Modaplex System - Expression Panels Product Overview
Modaplex System - Fungal Panel Assay
Modaplex System - Fungal Panel Assay Product Overview
Modaplex System - Insertions
Modaplex System - Insertions Product Overview
Modaplex System - microRNA/mRNA/gDNA Panel
Modaplex System - microRNA/mRNA/gDNA Panel Product Overview
Modaplex System - Mixed Pathogen Panels
Modaplex System - Mixed Pathogen Panels Product Overview
Modaplex System - Polysomy
Modaplex System - Polysomy Product Overview
Modaplex System - Respiratory Panel Assay
Modaplex System - Respiratory Panel Assay Product Overview
Modaplex System - SNP Panels
Modaplex System - SNP Panels Product Overview
Modaplex System - STI Panel Assay
Modaplex System - STI Panel Assay Product Overview
Modaplex System - Transplant Panel
Modaplex System - Transplant Panel Product Overview
Modaplex System - Ultra-Sensitive JCV/BKV Panel
Modaplex System - Ultra-Sensitive JCV/BKV Panel Product Overview
mSEPT9 Colorectal Cancer Test
mSEPT9 Colorectal Cancer Test Product Overview
Prognosis Test - Prostate Cancer
Prognosis Test - Prostate Cancer Product Overview
QIAact Breast Panel (Expanded)
QIAact Breast Panel (Expanded) Product Overview
QIAact Gene Expression Signatures
QIAact Gene Expression Signatures Product Overview
QIAact Lung Panel (CNV And Fusion)
QIAact Lung Panel (CNV And Fusion) Product Overview
QIAact Onco-Heme Panel - Myeloid
QIAact Onco-Heme Panel - Myeloid Product Overview
QIAensemble 400 - Bacterial Vaginosis
QIAensemble 400 - Bacterial Vaginosis Product Overview
QIAensemble 400 - Candida Species
QIAensemble 400 - Candida Species Product Overview
QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea
QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea Product Overview
QIAensemble 400 - Group B Streptococci
QIAensemble 400 - Group B Streptococci Product Overview
QIAensemble 400 - Herpes Simplex Virus 1 and 2
QIAensemble 400 - Herpes Simplex Virus 1 and 2 Product Overview
QIAensemble 400 - Trichomonas Vaginalis
QIAensemble 400 - Trichomonas Vaginalis Product Overview
QIAensemble JE2000
QIAensemble JE2000 Product Overview
QIAensemble SP/2000 With Screening And Genotyping
QIAensemble SP/2000 With Screening And Genotyping Product Overview
Qiagen Digital PCR System
Qiagen Digital PCR System Product Overview
QIAstat-Dx Multiplex - Meningitis / Encephalitis
QIAstat-Dx Multiplex - Meningitis / Encephalitis Product Overview
QIAstat-Dx System
QIAstat-Dx System Product Overview
QIAstat-Dx System - Oncology Assay
QIAstat-Dx System - Oncology Assay Product Overview
QIAsymphony - C. Difficile Assay
QIAsymphony - C. Difficile Assay Product Overview
QIAsymphony - Malaria
QIAsymphony - Malaria Product Overview
QIAsymphony - WNV (West Nile Virus)
QIAsymphony - WNV (West Nile Virus) Product Overview
QIAsymphony - ALK Assay
QIAsymphony - ALK Assay Product Overview
QIAsymphony - EGFR Assay 0
QIAsymphony - EGFR Assay Product Overview 0
QIAsymphony - Enhance HCV Limit of Detection
QIAsymphony - Enhance HCV Limit of Detection Product Overview
QIAsymphony - ESBL
QIAsymphony - ESBL Product Overview
QIAsymphony - Group B Streptococcal Infections
QIAsymphony - Group B Streptococcal Infections Product Overview
QIAsymphony - HEV
QIAsymphony - HEV Product Overview
QIAsymphony - MRSA
QIAsymphony - MRSA Product Overview
QIAsymphony - NRAS Assay
QIAsymphony - NRAS Assay Product Overview
QIAsymphony - T315I
QIAsymphony - T315I Product Overview
QIAsymphony RGQ - Artus HIV-1 Test
QIAsymphony RGQ - Artus HIV-1 Test Product Overview
QIAsymphony RGQ - HPV Assay
QIAsymphony RGQ - HPV Assay Product Overview
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Melanoma 0
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Melanoma Product Overview 0
QuantiFERON - CMV Test
QuantiFERON - CMV Test Product Overview
QuantiFERON - CMV Test Clinical Trial
QuantiFERON - Leishmania Test
QuantiFERON - Leishmania Test Product Overview
QuantiFERON - TB Access
QuantiFERON - TB Access Product Overview
QuantiFERON Monitor
QuantiFERON Monitor Product Overview
QuantiFERON Monitor Clinical Trial
QuantiFERON-TB Gold Plus - LIAISON XL
QuantiFERON-TB Gold Plus - LIAISON XL Product Overview
ResPlex II
ResPlex II Product Overview
Therascreen EGFR Assay - Rociletinib
Therascreen EGFR Assay - Rociletinib Product Overview
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer Product Overview
Therascreen KRAS Assay - Dacomitinib
Therascreen KRAS Assay - Dacomitinib Product Overview
Therascreen PI3K RGQ PCR Kit
Therascreen PI3K RGQ PCR Kit Product Overview
ViraQuant
ViraQuant Product Overview
Qiagen NV - Key Competitors
Qiagen NV - Key Employees
Qiagen NV - Key Employee Biographies
Qiagen NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Qiagen NV, Recent Developments
Jun 07, 2019: Qiagen and DiaSorin to develop test for Lyme disease
May 28, 2019: NeoGenomics and QIAGEN collaborate to offer companion diagnostic test for HR+/HER2 - advanced breast cancer patients to detect a PIK3CA mutation
May 28, 2019: Qiagen introduces companion diagnostic for breast cancer
May 23, 2019: QIAGEN and U.K. alliance launch APIS Assay Technologies to expand biomarker research and foster healthcare innovation
May 21, 2019: QIAGENs QuantiFERON-TB Access development program gains recognition from United Nations initiative for health innovation
May 20, 2019: Qiagen and Inovio partner to develop companion diagnostic
May 20, 2019: QIAGEN gains 510(k) clearance by FDA for QIAstat-Dx in the U.S. and launches system as next generation platform for syndromic insights
May 10, 2019: LabCorp announces availability of new QIAGEN therascreen FGFR mutation analysis companion diagnostic for Bladder Cancer
May 06, 2019: QIAGEN reports results for first quarter of 2019 and announces plans for new $100 Million share repurchase program
Apr 12, 2019: BALVERSA (erdafitinib) receives U.S. FDA approval for the treatment of patients with locally advanced or metastatic urothelial carcinoma with certain FGFR genetic alterations
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List Of Tables
Qiagen NV Pipeline Products and Ongoing Clinical Trials Overview
Qiagen NV Pipeline Products by Equipment Type
Qiagen NV Pipeline Products by Indication
Qiagen NV Ongoing Clinical Trials by Trial Status
Qiagen NV, Key Facts
Qiagen NV, Major Products and Services
Qiagen NV Number of Pipeline Products by Development Stage
Qiagen NV Pipeline Products Summary by Development Stage
Qiagen NV Ongoing Clinical Trials by Trial Status
Qiagen NV Ongoing Clinical Trials Summary
AdnaTest OvarianCancerSelect - Product Status
AdnaTest OvarianCancerSelect - Product Description
AdnaTest ProstateCancerDetect - Product Status
AdnaTest ProstateCancerDetect - Product Description
AR-V7 Companion Diagnostic Test - Product Status
AR-V7 Companion Diagnostic Test - Product Description
Blood Based Test - Colorectal Cancer - Product Status
Blood Based Test - Colorectal Cancer - Product Description
Colon Cancer Test - Stage III And IV Patient - Product Status
Colon Cancer Test - Stage III And IV Patient - Product Description
Companion Diagnostic Assay - EGFR vIII - Product Status
Companion Diagnostic Assay - EGFR vIII - Product Description
Companion Diagnostic Assay - MGCD265 - Product Status
Companion Diagnostic Assay - MGCD265 - Product Description
Companion Diagnostic Assay - Oncology - Product Status
Companion Diagnostic Assay - Oncology - Product Description
Companion Diagnostic Test - ASP5878 - Product Status
Companion Diagnostic Test - ASP5878 - Product Description
Companion Diagnostic Test - ASP8273 - Product Status
Companion Diagnostic Test - ASP8273 - Product Description
Companion Diagnostic Test - Binimetinib - Product Status
Companion Diagnostic Test - Binimetinib - Product Description
Companion Diagnostic Test - EZH2 Y641 - Product Status
Companion Diagnostic Test - EZH2 Y641 - Product Description
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Status
Companion Diagnostic Test - IDH1/IDH2 Gene - Product Description
DiagCORE Blood Culture Identification Panel - Product Status
DiagCORE Blood Culture Identification Panel - Product Description
DiagCORE Central Nervous System Panel - Product Status
DiagCORE Central Nervous System Panel - Product Description
DiagCORE Gastrointestinal Panel - Product Status
DiagCORE Gastrointestinal Panel - Product Description
DiagCORE Pneumonia Panel - Product Status
DiagCORE Pneumonia Panel - Product Description
Diagnostic Test - FGFR-TACC - Product Status
Diagnostic Test - FGFR-TACC - Product Description
Diagnostic Test - T-Cell Lymphoma - Product Status
Diagnostic Test - T-Cell Lymphoma - Product Description
GeneRead QIAact Lung All-in-One Assay - Product Status
GeneRead QIAact Lung All-in-One Assay - Product Description
GeneReader NGS - Leukemia Panel - Product Status
GeneReader NGS - Leukemia Panel - Product Description
GeneReader NGS - MPN Panel - Product Status
GeneReader NGS - MPN Panel - Product Description
GeneReader NGS System - Product Status
GeneReader NGS System - Product Description
GeneReader NGS System - BRCA Liquid Biopsy Assay - Product Status
GeneReader NGS System - BRCA Liquid Biopsy Assay - Product Description
GeneReader NGS System - FFPE BRCA Assay - Product Status
GeneReader NGS System - FFPE BRCA Assay - Product Description
GeneReader NGS System - Infectious Disease - Product Status
GeneReader NGS System - Infectious Disease - Product Description
Genetic Test - Prostate Cancer - Product Status
Genetic Test - Prostate Cancer - Product Description
ipsogen JAK2 RGQ PCR Kit - Product Status
ipsogen JAK2 RGQ PCR Kit - Product Description
miRNA Biomarker - Cancer of Unknown Primary - Product Status
miRNA Biomarker - Cancer of Unknown Primary - Product Description
miRNA Test - Endometrial Cancer - Product Status
miRNA Test - Endometrial Cancer - Product Description
miRNA Test - Lung Cancer - Product Status
miRNA Test - Lung Cancer - Product Description
miRNA test - Ovarian Cancer - Product Status
miRNA test - Ovarian Cancer - Product Description
Modaplex System - B-Cell Lymphoma Panel - Product Status
Modaplex System - B-Cell Lymphoma Panel - Product Description
Modaplex System - BCR-ABL Panel - Product Status
Modaplex System - BCR-ABL Panel - Product Description
Modaplex System - Cancer - Product Status
Modaplex System - Cancer - Product Description
Modaplex System - cMET Mutation Panel - Product Status
Modaplex System - cMET Mutation Panel - Product Description
Modaplex System - Copy Number Variation - Product Status
Modaplex System - Copy Number Variation - Product Description
Modaplex System - Deletions - Product Status
Modaplex System - Deletions - Product Description
Modaplex System - Drug Metabolism - Product Status
Modaplex System - Drug Metabolism - Product Description
Modaplex System - EML4-ALK - Product Status
Modaplex System - EML4-ALK - Product Description
Modaplex System - Expression Panels - Product Status
Modaplex System - Expression Panels - Product Description
Modaplex System - Fungal Panel Assay - Product Status
Modaplex System - Fungal Panel Assay - Product Description
Modaplex System - Insertions - Product Status
Modaplex System - Insertions - Product Description
Modaplex System - microRNA/mRNA/gDNA Panel - Product Status
Modaplex System - microRNA/mRNA/gDNA Panel - Product Description
Modaplex System - Mixed Pathogen Panels - Product Status
Modaplex System - Mixed Pathogen Panels - Product Description
Modaplex System - Polysomy - Product Status
Modaplex System - Polysomy - Product Description
Modaplex System - Respiratory Panel Assay - Product Status
Modaplex System - Respiratory Panel Assay - Product Description
Modaplex System - SNP Panels - Product Status
Modaplex System - SNP Panels - Product Description
Modaplex System - STI Panel Assay - Product Status
Modaplex System - STI Panel Assay - Product Description
Modaplex System - Transplant Panel - Product Status
Modaplex System - Transplant Panel - Product Description
Modaplex System - Ultra-Sensitive JCV/BKV Panel - Product Status
Modaplex System - Ultra-Sensitive JCV/BKV Panel - Product Description
mSEPT9 Colorectal Cancer Test - Product Status
mSEPT9 Colorectal Cancer Test - Product Description
Prognosis Test - Prostate Cancer - Product Status
Prognosis Test - Prostate Cancer - Product Description
QIAact Breast Panel (Expanded) - Product Status
QIAact Breast Panel (Expanded) - Product Description
QIAact Gene Expression Signatures - Product Status
QIAact Gene Expression Signatures - Product Description
QIAact Lung Panel (CNV And Fusion) - Product Status
QIAact Lung Panel (CNV And Fusion) - Product Description
QIAact Onco-Heme Panel - Myeloid - Product Status
QIAact Onco-Heme Panel - Myeloid - Product Description
QIAensemble 400 - Bacterial Vaginosis - Product Status
QIAensemble 400 - Bacterial Vaginosis - Product Description
QIAensemble 400 - Candida Species - Product Status
QIAensemble 400 - Candida Species - Product Description
QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea - Product Status
QIAensemble 400 - Chlamydia Trachomatis/Neisseria Gonorrhea - Product Description
QIAensemble 400 - Group B Streptococci - Product Status
QIAensemble 400 - Group B Streptococci - Product Description
QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Status
QIAensemble 400 - Herpes Simplex Virus 1 and 2 - Product Description
QIAensemble 400 - Trichomonas Vaginalis - Product Status
QIAensemble 400 - Trichomonas Vaginalis - Product Description
QIAensemble JE2000 - Product Status
QIAensemble JE2000 - Product Description
QIAensemble SP/2000 With Screening And Genotyping - Product Status
QIAensemble SP/2000 With Screening And Genotyping - Product Description
Qiagen Digital PCR System - Product Status
Qiagen Digital PCR System - Product Description
QIAstat-Dx Multiplex - Meningitis / Encephalitis - Product Status
QIAstat-Dx Multiplex - Meningitis / Encephalitis - Product Description
QIAstat-Dx System - Product Status
QIAstat-Dx System - Product Description
QIAstat-Dx System - Oncology Assay - Product Status
QIAstat-Dx System - Oncology Assay - Product Description
QIAsymphony - C. Difficile Assay - Product Status
QIAsymphony - C. Difficile Assay - Product Description
QIAsymphony - Malaria - Product Status
QIAsymphony - Malaria - Product Description
QIAsymphony - WNV (West Nile Virus) - Product Status
QIAsymphony - WNV (West Nile Virus) - Product Description
QIAsymphony - ALK Assay - Product Status 9
QIAsymphony - ALK Assay - Product Description 9
QIAsymphony - EGFR Assay - Product Status 0
QIAsymphony - EGFR Assay - Product Description 0
QIAsymphony - Enhance HCV Limit of Detection - Product Status
QIAsymphony - Enhance HCV Limit of Detection - Product Description
QIAsymphony - ESBL - Product Status
QIAsymphony - ESBL - Product Description
QIAsymphony - Group B Streptococcal Infections - Product Status
QIAsymphony - Group B Streptococcal Infections - Product Description
QIAsymphony - HEV - Product Status
QIAsymphony - HEV - Product Description
QIAsymphony - MRSA - Product Status
QIAsymphony - MRSA - Product Description
QIAsymphony - NRAS Assay - Product Status
QIAsymphony - NRAS Assay - Product Description
QIAsymphony - T315I - Product Status
QIAsymphony - T315I - Product Description
QIAsymphony RGQ - Artus HIV-1 Test - Product Status
QIAsymphony RGQ - Artus HIV-1 Test - Product Description
QIAsymphony RGQ - HPV Assay - Product Status 9
QIAsymphony RGQ - HPV Assay - Product Description 9
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Melanoma - Product Status 0
QIAsymphony RGQ Upgrade - Therascreen BRAF Kit - Melanoma - Product Description 0
QuantiFERON - CMV Test - Product Status 1
QuantiFERON - CMV Test - Product Description 1
QuantiFERON - CMV Test - Assessing the Impact and Complications of Cytomegalovirus (CMV) Reactivation in a Multi-site Study of Allogeneic Haematopoietic Stem Cell Transplant Recipient
QuantiFERON - CMV Test - Clinical Evaluation of the QuantiFERON CMV Assay
QuantiFERON - CMV Test - Risk of Cytomegalovirus Disease or High Viremia in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV
QuantiFERON - Leishmania Test - Product Status
QuantiFERON - Leishmania Test - Product Description
QuantiFERON - TB Access - Product Status
QuantiFERON - TB Access - Product Description
QuantiFERON Monitor - Product Status
QuantiFERON Monitor - Product Description
QuantiFERON Monitor - Assessing the Impact and Complications of Cytomegalovirus (CMV) Reactivation in a Multi-site Study of Allogeneic Haematopoietic Stem Cell Transplant Recipient
QuantiFERON-TB Gold Plus - LIAISON XL - Product Status
QuantiFERON-TB Gold Plus - LIAISON XL - Product Description
ResPlex II - Product Status
ResPlex II - Product Description
Therascreen EGFR Assay - Rociletinib - Product Status 9
Therascreen EGFR Assay - Rociletinib - Product Description 9
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Status
Therascreen JAK2 Companion Diagnostic Test - Blood Cancer - Product Description
Therascreen KRAS Assay - Dacomitinib - Product Status
Therascreen KRAS Assay - Dacomitinib - Product Description
Therascreen PI3K RGQ PCR Kit - Product Status
Therascreen PI3K RGQ PCR Kit - Product Description
ViraQuant - Product Status
ViraQuant - Product Description
Qiagen NV, Key Employees
Qiagen NV, Key Employee Biographies
Qiagen NV, Subsidiaries
Qiagen NV, Joint Venture
Glossary
List Of Figures
Qiagen NV Pipeline Products by Equipment Type
Qiagen NV Pipeline Products by Development Stage
Qiagen NV Ongoing Clinical Trials by Trial Status
RELATED REPORTS
Qiagen NV (QIA) - Product Pipeline Analysis, 2020 Update
Qiagen NV (Qiagen) is a provider of molecular testing solutions. The companys sample technologies help isolate and process DNA, RNA and proteins from samples such as blood, tissue and other
View ReportCOVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)
COVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)Qiagen provides molecular testing solutions including instruments, consumables and automation systems for molecular diagnostics, applied testing, pharma and academia markets worldwide.
View ReportQiagen NV (QIA) - Product Pipeline Analysis, 2020 Update
Qiagen NV (Qiagen) is a provider of molecular testing solutions. The companys sample technologies help isolate and process DNA, RNA and proteins from samples such as blood, tissue and other
View ReportCOVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)
COVID-19 Impact on Qiagen NVs Revenue and Operations (Medical Devices)Qiagen provides molecular testing solutions including instruments, consumables and automation systems for molecular diagnostics, applied testing, pharma and academia markets worldwide.
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
